INVESTOR LOGIN

Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »

home About Us People Portfolio Contact Us Fund II Investor Login » Fund III Investor Login » Fund IV Investor Login » Fund V Investor Log In »

portfolio

The CRG investment team has provided a dynamic array of financing solutions for companies across all healthcare sectors.

$50 million

Medical Device
ENT

$50 million

Medical Device
Cardiovascular

Undisclosed

Medical Device
Urology

Undisclosed

Medical Device
Neurology

Undisclosed

Healthcare Services & IT
Addiction Medicine

Undisclosed

Healthcare Services & IT
Medicare Advantage

$45 million

Medical Device
ENT / Hearing Loss

Undisclosed

Tools & Diagnostics
At-home Health Testing

Undisclosed

Healthcare Services & IT
Outpatient Behavioral Health

$65 million

Healthcare Services & IT
Physician Services

Undisclosed

Healthcare Services & IT
Managed Care

$29 million

Medical Device
Spine

Undisclosed

Healthcare Services & IT
Dental Services

Undisclosed

Heathcare Services & IT
Primary Care

$30 million

Healthcare Services & IT
Dermatology

Undisclosed

Medical Device
Neurology

Undisclosed

Medical Device
Orthopedics

Undisclosed

Consumer Healthcare
Wearable

Undisclosed

Healthcare Services & IT
Primary Care

$55 million

Medical Device
Wound Care

Undisclosed

Healthcare Services & IT
Concierge Urgent & Emergency Care

$50 million

Tools & Diagnostics
Infectious Diseases

Undisclosed

Heathcare Services & IT
Pharmacy Optimization

Undisclosed

Healthcare Services & IT
Cardiology

Undisclosed

Healthcare Services & IT
Managed Care

Current

Undisclosed

Healthcare Services & IT
Telemedicine

$53 million

Specialty Pharmaceuticals
Various

Undisclosed

Healthcare Services & IT
Medicare Advantage

$56 million

Tools & Diagnostics
Nephrology

Undisclosed

Medical Device
Neurology

Undisclosed

Medical Device
Spine

$77 million

Specialty Pharmaceuticals
Pain

$20 million

Tools & Diagnostics
Oncology

$20 million

Specialty Pharmaceuticals
Animal Health and Oncology

Undisclosed

Pharmaceutical Services
CDMO

$44 million

Medical Device
Orthopedic

$27 million

Medical Device
Orthopedic

Undisclosed

Pharmaceutical Services
CDMO

$47 million

Specialty Pharmaceuticals
Drug Delivery

$40 million

Specialty Pharmaceuticals
Infectious Diseases and Cardiovascular

Undisclosed

Tools & Diagnostics
Oncology

$175 million

Biopharma
Infectious Diseases and Oncology

$86 million

Biopharma
Women's Health

$51 million

Medical Device
Gastroenterology

$25 million

Tools & Diagnostics
Autoimmune

$60 million

Biopharma
Ophthalmology

Undisclosed

Healthcare Services & IT
Urgent Care

$18 million

Tools & Diagnostics
Women's Health

Undisclosed

Biopharma
Neurology

Undisclosed

Healthcare Services & IT
Tech-Enabled Engagement

$85 million

Healthcare Services & IT
Radiology

Undisclosed

Specialty Pharmaceuticals
Pain

Undisclosed

Healthcare Services & IT
Telemedicine

$80 million

Tools & Diagnostics
Research Oncology

$50 million

Tools & Diagnostics
Oncology

$75 million

Medical Device
Urology

$20 million

Medical Device
Pain

$125 million

Biopharma
Various

$35 million

Medical Device
Nephrology

Undisclosed

Medical Device
Cardiology

$35 million

Tools & Diagnostics
Oncology

$44 million

Medical Device
Cardiovascular

$60 million

Medical Device
Aesthetics

$68 million

Healthcare Services & IT
Telemedicine

$88 million

Biopharma
Rare Diseases

$100 million

Biopharma
Gastrointestinal

$80 million

Medical Device
Endocrinology

$35 million

Tools & Diagnostics
Ophthalmology

$50 million

Medical Device
Orthopedics

$96 million

Medical Device
Cardiovascular

Undisclosed

Specialty Pharmaceuticals
CNS

Undisclosed

Medical Device
Endocrinology

$48 million

Medical Device
Oncology

$30 million

Medical Device
Women's Health

Note: Excludes royalty investments made in Fund I.

Exited

Undisclosed

Healthcare Services & IT
Telemedicine

$50 million

Medical Device
ENT

$53 million

Specialty Pharmaceuticals
Various

Undisclosed

Healthcare Services & IT
Medicare Advantage

$56 million

Tools & Diagnostics
Nephrology

Undisclosed

Medical Device
Neurology

$50 million

Medical Device
Cardiovascular

Undisclosed

Medical Device
Spine

$77 million

Specialty Pharmaceuticals
Pain

$20 million

Tools & Diagnostics
Oncology

$20 million

Specialty Pharmaceuticals
Animal Health and Oncology

Undisclosed

Pharmaceutical Services
CDMO

$44 million

Medical Device
Orthopedic

Undisclosed

Medical Device
Urology

Undisclosed

Medical Device
Neurology

$27 million

Medical Device
Orthopedic

Undisclosed

Healthcare Services & IT
Addiction Medicine

Undisclosed

Healthcare Services & IT
Medicare Advantage

Undisclosed

Pharmaceutical Services
CDMO

$47 million

Specialty Pharmaceuticals
Drug Delivery

$40 million

Specialty Pharmaceuticals
Infectious Diseases and Cardiovascular

Undisclosed

Tools & Diagnostics
Oncology

$175 million

Biopharma
Infectious Diseases and Oncology

$45 million

Medical Device
ENT / Hearing Loss

$86 million

Biopharma
Women's Health

$51 million

Medical Device
Gastroenterology

Undisclosed

Tools & Diagnostics
At-home Health Testing

$25 million

Tools & Diagnostics
Autoimmune

$60 million

Biopharma
Ophthalmology

Undisclosed

Healthcare Services & IT
Outpatient Behavioral Health

Undisclosed

Healthcare Services & IT
Urgent Care

$18 million

Tools & Diagnostics
Women's Health

Undisclosed

Biopharma
Neurology

Undisclosed

Healthcare Services & IT
Tech-Enabled Engagement

$65 million

Healthcare Services & IT
Physician Services

Undisclosed

Healthcare Services & IT
Managed Care

$85 million

Healthcare Services & IT
Radiology

$29 million

Medical Device
Spine

Undisclosed

Specialty Pharmaceuticals
Pain

Undisclosed

Healthcare Services & IT
Telemedicine

Undisclosed

Healthcare Services & IT
Dental Services

Undisclosed

Heathcare Services & IT
Primary Care

$80 million

Tools & Diagnostics
Research Oncology

$30 million

Healthcare Services & IT
Dermatology

$50 million

Tools & Diagnostics
Oncology

$75 million

Medical Device
Urology

Undisclosed

Medical Device
Neurology

$20 million

Medical Device
Pain

$125 million

Biopharma
Various

Undisclosed

Medical Device
Orthopedics

Undisclosed

Consumer Healthcare
Wearable

$35 million

Medical Device
Nephrology

Undisclosed

Healthcare Services & IT
Primary Care

Undisclosed

Medical Device
Cardiology

$35 million

Tools & Diagnostics
Oncology

$55 million

Medical Device
Wound Care

$44 million

Medical Device
Cardiovascular

Undisclosed

Healthcare Services & IT
Concierge Urgent & Emergency Care

$60 million

Medical Device
Aesthetics

$68 million

Healthcare Services & IT
Telemedicine

$88 million

Biopharma
Rare Diseases

$100 million

Biopharma
Gastrointestinal

$50 million

Tools & Diagnostics
Infectious Diseases

$80 million

Medical Device
Endocrinology

$35 million

Tools & Diagnostics
Ophthalmology

$50 million

Medical Device
Orthopedics

$96 million

Medical Device
Cardiovascular

Undisclosed

Heathcare Services & IT
Pharmacy Optimization

Undisclosed

Healthcare Services & IT
Cardiology

Undisclosed

Specialty Pharmaceuticals
CNS

Undisclosed

Medical Device
Endocrinology

$48 million

Medical Device
Oncology

$30 million

Medical Device
Women's Health

Undisclosed

Healthcare Services & IT
Managed Care

Note: Excludes royalty investments made in Fund I.

All

© CRG 2024 ALL RIGHTS RESERVED

© CR GROUP 2024 ALL RIGHTS RESERVED

Contact Us | Privacy Policy | TERMS AND CONDITIONS